Structure and Composition Define Immunorecognition of Nucleic Acid Nanoparticles

Area of Science:

• Biotechnology
• Immunology
• Nanomedicine

Background:

• Nucleic acid nanoparticles (NANPs) represent a promising therapeutic class.
• However, their immunotoxicity remains a significant barrier to clinical application.
• Previous studies on traditional therapeutic nucleic acids (TNAs) offer limited insight into NANP immunobiology.

Purpose of the Study:

• To systematically investigate the immunological recognition of diverse RNA and DNA NANPs.
• To characterize the immunotoxicity profile of NANPs independent of delivery carriers.
• To elucidate the cellular and molecular mechanisms underlying NANP-immune system interactions.

Main Methods:

• Systematic immunological evaluation of 25 distinct RNA and DNA NANPs.
• Analysis of cytokine profiles, including interferons (IFNs).
• Investigation of cellular uptake pathways and Toll-like receptor (TLR) signaling.

Main Results:

• NANPs, when used without carriers, are largely immunoquiescent.
• Interferons (type I and III) are key cytokines triggered by NANPs.
• Immune stimulation depends on NANP design (shape, connectivity, composition).
• Plasmacytoid dendritic cells are primary IFN producers, with scavenger receptor uptake and endosomal TLR signaling being crucial.
• TLR involvement differs from TNA recognition patterns.

Conclusions:

• NANPs exhibit a distinct immunomodulatory profile compared to TNAs.
• NANP immunogenicity is tunable via design parameters.
• NANP technology holds potential for immune system communication and therapeutic modulation.